Pilar Santisteban

Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer

Mingzhao Xing, Ali S. Alzahrani, Kathryn A. Carson et al. · JAMA · 2013 · 926 citations

Medicine, Molecular Medicine, Oncology +15

mRNA circularization by METTL3–eIF3h enhances translation and promotes oncogenesis

Junho Choe, Shuibin Lin, Wen Cai Zhang et al. · Nature · 2018 · 797 citations

Life Sciences, Cancer Biology, Molecular Biology +14

Association Between <i>BRAF</i> V600E Mutation and Recurrence of Papillary Thyroid Cancer

Mingzhao Xing, Ali S. Alzahrani, Kathryn A. Carson et al. · Journal of Clinical Oncology · 2014 · 521 citations · Full text

Medicine, Molecular Genetics, Oncology +14

The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I− targeting to the membrane

Garcilaso Riesco‐Eizaguirre, Paula Gutierrez‐Martinez, Miguel Ángel García‐Cabezas et al. · Endocrine Related Cancer · 2006 · 369 citations · Full text

Medicine, Molecular Genetics, Oncology +17

The BRAFV600E Oncogene Induces Transforming Growth Factor β Secretion Leading to Sodium Iodide Symporter Repression and Increased Malignancy in Thyroid Cancer

Garcilaso Riesco‐Eizaguirre, Irene Rodrı́guez, Antonio De la Vieja et al. · Cancer Research · 2009 · 262 citations

Medicine, Cancer Biology, Oncology +17